Panagora Asset Management Inc Savara Inc Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$1.17 - $2.33 $795 - $1,584	-680 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.09 - $2.21 $741 - $1,502	680 New	680 $1,000
Q2 2020 Aug 12, 2020	SELL	$1.8 - $3.05 $3,976 - $6,737	-2,209 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.16 - $3.2 $2,088 - $3,094	-967 Reduced 30.45%	2,209 $6,000
Q2 2019 Aug 09, 2019	BUY	$2.37 - $11.7 $7,527 - $37,159	3,176 New	3,176 $8,000

133

151M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $318M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.